Clinical Trials Browser

Phase 2/3 × Autistic Disorder × Everolimus × Clear all

NCT07218575 2025-10-20

Double-Blind Trial of Everolimus for Improving Social Abilities in PTEN Germline Mutations

Phase 2/3 Not yet recruiting

Autistic Disorder, Hamartoma Syndrome, Multiple

NCT01730209 2015-05-05

RAPIT

Phase 2/3 Unknown

Autistic Disorder, Intellectual Disability, Tuberous Sclerosis